A
_Abyssinia
Guest
Researchers from the Fred Hutchinson Cancer Research Center published a study in the 2012 Journal of Cancer Research. They looked specifically at depo provera and found it doubles the risk of breast cancer:
cancerres.aacrjournals.org/content/early/2012/02/25/0008-5472.CAN-11-4064.abstract
Excerpt from interview with Dr. Timothy Flanigan:
Doesn’t Melinda Gates know of this research?
cancerres.aacrjournals.org/content/early/2012/02/25/0008-5472.CAN-11-4064.abstract
Excerpt from interview with Dr. Timothy Flanigan:
It was a very large study that involved seven African countries. The researchers looked at couples with one HIV-positive spouse and one HIV-negative spouse.
The study was designed to look at whether suppressing the herpes virus would decrease HIV transmission. They enrolled well over 3,000 couples, mostly from sub-Saharan Africa.
Since hormonal contraceptives, especially Depo-Provera, are widely promoted in sub-Saharan Africa, the study provided an opportunity to see whether oral or injectable contraception would increase or decrease the risk of HIV transmission. What they found was very concerning: The hormonal contraception widely touted and promoted doubles the risk of acquisition and transmission of HIV.
The study was very well done, coordinated by the University of Washington in Seattle. The results are alarming and have significant implications for programs that actively promote the use of hormonal contraception.
The study was presented at the International AIDS Society in Rome last summer and was then published in the October issue of Lancet Infectious Diseases, a premier medical journal.
ncregister.com/daily-news/understanding-the-international-effort-of-population-control#ixzz3E2FQTwnWSince the study was published, the National Institutes of Health (NIH), UNAIDS and the World Health Organization (WHO) have convened panels to review the research about how hormonal contraception increases the risk of heterosexual transmission of HIV.
Doesn’t Melinda Gates know of this research?